The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

Recruiting now · Not applicable

Conditions studied: Sarcopenia in Elderly, Malnourished, Protein Supplementation, Muscle Mass, Physical Function, Strength

In brief

Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia

Key facts

Study ID

NCT07322653

Run by

Nuritas Ltd

People needed

75

Starts

2025-09-10

Expected to finish

2027-01-02

Last updated by the study team

2026-01-07

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 60 years or older
• BMI ≤ 25 kg/m²
• Malnourished (mini nutritional assessment MNA <11
• Sarcopenic: SARC-F score ≥ 4
• Capable or oral feeding either alone or assisted
• Ambulatory (WHO PS/ECOG 0-3)
• Ability to complete questionnaires and self assess health status
• Ability to provide consent

You may not qualify if…

• Patient cannot eat orally
• Acute Infection
• Proven Intestinal obstruction
• Co-morbidities requiring a special diet (diabetes, kidney disease etc.)
• Liver dysfunction
• Acute or chronic renal failure
• Uncontrollable nausea or vomiting
• Use of megestrol acetate or metabolic steroids
• Dietary supplement use in the last 3 months
• Known intolerance or allergy to the investigational products
• Participation in any clinical trial within the last 3 months

Where it is running

• Országos Korányi Pulmonológiai Intézet — Budapest, Hungary (enrolling)
• Sóstói Szivárvány Idősek Otthona — Nyíregyháza, Hungary (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.